How healthcare VC firms are thinking about longevity
Christina Farr
8 min read
7wire shared their thesis and market map with us that it created for its own LPs
Markets
Weekly News: The HIMs/Novo breakup, digital health reimbursements and new funding rounds
Christina Farr and Annalisa Merelli
7 min read
Drama between an online prescriber and the pharma company was the most interesting drama of the week
The biggest winners from the Hinge IPO - and what that says about digital health investing
Christina Farr and Rebecca Mitchell
8 min read
One tiny fund I hadn’t heard of absolutely crushed it
Should you build relationships with VCs before a raise? That’s a hard yes.
Christina Farr
9 min read
This is a hot topic and I’ve heard plenty of arguments with both sides. Here’s my POV.
Some tough questions VCs and founders need to address out in the open
Christina Farr and Saurabh Bhansali
12 min read
What are the hidden trade offs of fund size. When should founders be able to take money off the table?
Part III: Building your women's health business without venture capital
Leslie Schrock and Carolyn Witte
8 min read
Sometimes a little less money is the right outcome
Part II: Game Planning Your Women’s Health Raise
Leslie Schrock and Carolyn Witte
8 min read
When to raise, how much & from whom?
Is your women's health business venture backable?
Leslie Schrock and Carolyn Witte
9 min read
Part 1 in our founder's guide to financing your women's health startup
Navigating Black Swan Events in Volatile Markets
Christina Farr and Meghan Fitzgerald
10 min read
How healthcare founders should take lessons from teams navigating unpredictable events
23andMe should have raised less capital
Christina Farr
6 min read
My takeaway from today’s news that the company is filing for bankruptcy
What happened to the digital health unicorns of 2020 to 2022?
Halle Tecco
10 min read
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!